A Simple Blood Test Could Lead to Personalized Therapies for Rheumatoid Arthritis and Related Diseases
source: pixabay.com

A Simple Blood Test Could Lead to Personalized Therapies for Rheumatoid Arthritis and Related Diseases

A recent study led by Morten Aagaard Nielsen and Tue Wenzel Kragstrup, who both work at Aarhus University in Denmark, hopes to help physicians determine the best personalized treatment for…

Continue Reading A Simple Blood Test Could Lead to Personalized Therapies for Rheumatoid Arthritis and Related Diseases
IL-23 Inhibitors May be a Leading Treatment for Psoriasis and Psoriatic Arthritis
source: pixabay.com

IL-23 Inhibitors May be a Leading Treatment for Psoriasis and Psoriatic Arthritis

The 2019 European Academy of Dermatology and Venereology Congress was held in Madrid, Spain. During this conference, a symposium was held discussing IL-23 inhibition in psoriasis. Here are some of…

Continue Reading IL-23 Inhibitors May be a Leading Treatment for Psoriasis and Psoriatic Arthritis
The FDA Grants Breakthrough Therapy Designation for ORENCIA as a Treatment for Graft vs Host Disease
source: pixabay.com

The FDA Grants Breakthrough Therapy Designation for ORENCIA as a Treatment for Graft vs Host Disease

According to a story from Business Wire, the biopharmaceutical company Bristol-Myers Squibb has recently announced that the US Food and Drug Administration (FDA) has granted the company's drug abatacept (marketed…

Continue Reading The FDA Grants Breakthrough Therapy Designation for ORENCIA as a Treatment for Graft vs Host Disease
Results of Phase 3 Trial Suggest The Drug Cosentyx Could be Effective for Axial Spondyloarthritis
source: pixabay.com

Results of Phase 3 Trial Suggest The Drug Cosentyx Could be Effective for Axial Spondyloarthritis

According to a story from Ankylosing Spondylitis News, findings from a phase 3 clinical trial suggest that the drug secukinumab (marketed as Cosentyx) could be an effective treatment for non-radiographic…

Continue Reading Results of Phase 3 Trial Suggest The Drug Cosentyx Could be Effective for Axial Spondyloarthritis
A “Real World” Study Suggests That The Drug Apremilast Could be Useful for Behçet’s Disease
katicaj / Pixabay

A “Real World” Study Suggests That The Drug Apremilast Could be Useful for Behçet’s Disease

According to a story from rheumatology.medicinematters.com, a recent Italian real-world study has provided some evidence that the drug apremilast, which is considered a phosphodiesterase-4 inhibitor, could be a useful treatment…

Continue Reading A “Real World” Study Suggests That The Drug Apremilast Could be Useful for Behçet’s Disease
Biosimilar Drug for Ankylosing Spondylitis gets Approved by the FDA
stevepb / Pixabay

Biosimilar Drug for Ankylosing Spondylitis gets Approved by the FDA

According to a story from Ankylosing Spondylitis News, the drug Hadlima, which is a biosimilar to the drug Humira (adalimumab), was recently approved by the US Food and Drug Administration…

Continue Reading Biosimilar Drug for Ankylosing Spondylitis gets Approved by the FDA
Researchers Continue Search for Role of Type-1 Interferon Pathway in Rheumatic Disease
mohamed_hassan / Pixabay

Researchers Continue Search for Role of Type-1 Interferon Pathway in Rheumatic Disease

According to a publication from the Rheumatologist, past studies have suggested that type 1 interferons may play a significant role in determining susceptibility to several classic connective tissue diseases. Although…

Continue Reading Researchers Continue Search for Role of Type-1 Interferon Pathway in Rheumatic Disease

Otezla Receives FDA Approval for Treatment of Oral Sores that Characterize Behçet’s Disease

According to a press release from American biotechnology company Celgene Corporation, the American Food and Drug Administration (FDA) recently approved the Company's drug Otezla (generic name apremilast) for the treatment…

Continue Reading Otezla Receives FDA Approval for Treatment of Oral Sores that Characterize Behçet’s Disease

New Biosimilar Product to Humira Could Be Cheaper and Just as Effective for Ankylosing Spondylitis Patients

The most common treatment for autoimmune conditions such as ankylosing spondylitis, plaque psoriasis, Crohn's disease, juvenile idiopathic arthritis, and rheumatoid arthritis is currently a drug called Humira, created by AbbVie.…

Continue Reading New Biosimilar Product to Humira Could Be Cheaper and Just as Effective for Ankylosing Spondylitis Patients
This Drug Could Treat Psoriatic Arthritis and Ankylosing Spondylitis
12019 / Pixabay

This Drug Could Treat Psoriatic Arthritis and Ankylosing Spondylitis

According to a story from globenewswire.com, Galapagos NV and Gilead Sciences, Inc., recently announced that two clinical trials which were recently published in The Lancet demonstrated that the experimental treatment filgotinib could…

Continue Reading This Drug Could Treat Psoriatic Arthritis and Ankylosing Spondylitis
Four New Drugs Accepted by the Scottish Medicines Consortium
qimono / Pixabay

Four New Drugs Accepted by the Scottish Medicines Consortium

The Scottish Medicines Consortium, a committee that advises NHS Scotland on what medicines they should provide, has accepted four new drugs for use. These are gemtuzumab ozogamicin for acute myeloid…

Continue Reading Four New Drugs Accepted by the Scottish Medicines Consortium
Let’s Come Together for World Autoimmune Arthritis Day!
Source: Pixabay

Let’s Come Together for World Autoimmune Arthritis Day!

Sunday, May 20th is World Autoimmune Arthritis Day! The global awareness day is aimed at raising money, consciousness, and solidarity for the millions of people who suffer from one of many arthritic…

Continue Reading Let’s Come Together for World Autoimmune Arthritis Day!
Study Shows Female Psoriatic Arthritis Patients Have Higher Rates of Psychiatric Disorders
source: pixabay.com

Study Shows Female Psoriatic Arthritis Patients Have Higher Rates of Psychiatric Disorders

In data presented earlier this month in San Diego at the 2017 American College of Rheumatology Annual Meeting, researchers noted that female patients with psoriatic arthritis had significantly higher rates of…

Continue Reading Study Shows Female Psoriatic Arthritis Patients Have Higher Rates of Psychiatric Disorders